Lack of interferon beta-induced radiosensitization in four out of five human glioblastoma cell lines

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 5, 2003, Pages 1348-1357

  Schmidberger, Heinz ^a   Rave Fränk, Margret ^a   Lehmann, Jörg ^b   Weiss, Elisabeth ^a   Gerl, Lara ^a   Dettmer, Nadine ^a   Glomme, Sabine ^a   Hess, C F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Glioblastoma; In vitro; Interferon beta; Radiosensitization

Indexed keywords

CELL CULTURE; CELLS; TUMORS;

CELL LINES;

RADIOTHERAPY;

BETA INTERFERON;

ARTICLE; CELL GROWTH; CELL HETEROGENEITY; CELL LINE; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; GAMMA IRRADIATION; GENETIC ASSOCIATION; GLIOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; TUMOR CELL CULTURE;

EID: 0345269070     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04575-3     Document Type: Article

References (30)

1. Fine H.A., Wen P.Y., Robertson M., et al. A phase I trial of a new recombinant human β-interferon (BG9015) for the treatment of patients with recurrent gliomas. Cancer Res. 3:1997;381-387.
2. Hofer S., Herrmann R. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage. J Cancer Res Clin Oncol. 127:2001;91-95.
3. Schmidberger H., Rave-Frank M., Lehmann J., et al. Radiosensitizing effect of natural and recombinant beta-interferons in a human lung carcinoma in vitro. J Cancer Res Clin Oncol. 125:1999;350-356.
4. Schmidberger H., Rave-Frank M., Lehmann J., et al. The combined effect of interferon beta and radiation on five human tumor cell lines and embryonal lung fibroblasts. Int J Radiat Oncol Biol Phys. 43:1999;405-412.
5. Borden E.C., Wadler S. Interferons as biochemical modulators. Editorial. J Clin Oncol. 14:1996;2627-2630.
6. Borden E.C. Progress toward therapeutic application of interferons, Cancer. 54:1984;2770-2776.
7. Lokshin A.S., Mayotte J.E., Levitt M.L. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst. 87:1995;206-212.
8. McDonald S., Chang A., Rubin P., et al. Combined betaseron r (recombinant interferon beta) and radiation for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:1993;613-619.
9. Yung W.K., Prados M., Levin V.A., et al. Intravenous recombinant interferon beta in patients wiht recurrent malignant gliomas A phase I/II study. Int J Radiat Oncol Biol Phys. 9:1991;1945-1949.
10. Eck S.L., Alavi J.B., Judy K., et al. Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5 010CMVhIFN-beta): A phase I trial. Hum Gene Ther. 12:2001;97-113.
11. Wakabayashi T., Yoshida J., Mizuno M., et al. Effectiveness of interferon-β, ACNU, and radiation therapy in pediatric patients with brainstem glioma. Neurol Med Chir. 32:1992;942-946.
12. Hatano N., Wakabayashi T., Kajita Y., et al. Efficacy of post- operative adjuvant therapy with human interferon beta, MCNU and radiation (IMR) for malignant glioma comparison among three protocols. Acta Neurochir. 142:2000;633-639.
13. Packer R.J., Prados M., Phillips P., et al. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinantβ-interferon and hyperfractionated radiation therapy. Cancer. 77:1996;2150-2156.
14. Nakamura O., Maruo K., Ueyama Y., et al. Interactions of human fibroblast interferon with chemotherapeutic agents and radiation against human gliomas in nude mice. Neurol Res. 8:1986;152-156.
15. Nederman T., Benediktsson G. Effects of interferon on growth rate and radiation sensitivity of cultured, human glioma cells. Acta Radiol Oncol. 21:1982;231-234.
16. Allalunis-Turner M.J., Barron G.M., Day RS 3rd, et al. Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells. Int J Radiat Oncol Biol Phys. 22:1992;765-768.
17. Malone C., Schiltz P.M., Nayak S.K., et al. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro. Clin Cancer Res. 5:1999;417-423.
18. Steel GG, Terminology in the description of drug-radiation interactions. Int J Radiat Oncol Biol Phys. 5:1979;1145-1150.
19. Garrison J.I., Berens M.E., Shapiro J.R., et al. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J Neuro-oncol. 30:1996;213-223.
20. Vita J.R., Edwalds G.M., Gorey T., et al. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. Anticancer Res. 8:1988;297-302.
21. Yarosh D.B., Scudiero D.A., Yagi T., et al. Human tumor cell strains both unable to repair O6-methylguanine and hypersensitive to killing by human alpha and beta interferons. Carcinogenesis. 6:1985;883-886.
22. Grups J.W., Bange F.C. Interferon receptors on the surface of interferon-sensitive and interferon-resistant urothelial carcinomas. Urol Res. 18:1990;119-122.
23. Perea S.E., Geronimo H., Lopez Saura P. Expression of interferon alpha receptors in cell lines from human tumors. Relationship with the antiproliferative effect. Acta Cient Venez. 44:1993;22-27.
24. Rosenblum M.G., Yung W.K., Kelleher P.J., et al. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells Correlation of receptor binding, 2′,5′-oligoadenylate synthetase and protein kinase activity. J Interferon Res. 10:1990;141-151.
25. Yano H., Iemura A., Haramaki M., et al. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology. 29:1999;1708-1717.
26. Kopf J., Hanson C., Delle U., et al. Action of interferon alpha and beta on four human melanoma cell lines in vitro. Anticancer Res. 16:1996;791-798.
27. Gould M.N., Kakria R.C., Olson S., et al. Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J Interferon Res. 4:1984;123-128.
28. Runkel L., Pfeffer L., Lewerenz M., et al. Differences in activity between alpha and beta type I interferons explored by mutational analysis. J Biol Chem. 273:1998;8003-8008.
29. Stanzione S., Cimoli G., Debernardis D., et al. Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell lines. Mutat Res. 348:1995;131-135.
30. Arbaje Y.M., Bittner G., Yingling J.M., et al. Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. Interferon Res. 13:1993;25-32.